Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues

Journal of Nephrology

Volumn 27, Issue 4, 2014, Pages 431-437

  Charitaki, Evangelina ^a   Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Haemodialysis; Hypertension; Parathyroid hormone; Pulse wave velocity; Vitamin D

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALFACALCIDOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; COUMARIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; PARATHYROID HORMONE; VITAMIN D; BONE DENSITY CONSERVATION AGENT; HYDROXYCOLECALCIFEROL; TRIACYLGLYCEROL;

AGED; AORTIC AUGMENTATION INDEX; ARM CIRCUMFERENCE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY AUGMENTATION INDEX; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; DIASTOLIC RELAXATION INDEX; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PULSE WAVE; RISK ASSESSMENT; SCINTIGRAPHY; SCORING SYSTEM; ANALOGS AND DERIVATIVES; AORTA; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DRUG EFFECTS; ECHOGRAPHY; HEART VENTRICLE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTA; BLOOD PRESSURE; BONE DENSITY CONSERVATION AGENTS; CARDIOVASCULAR DISEASES; DRUG PRESCRIPTIONS; FEMALE; HEART VENTRICLES; HUMANS; HYDROXYCHOLECALCIFEROLS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PULSE WAVE ANALYSIS; RENAL DIALYSIS; TRIGLYCERIDES; VASCULAR STIFFNESS; VITAMIN D;

EID: 84904459296     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0040-9     Document Type: Article

References (34)

1. Green D, Roberts PR, New DI, Kalra PA (2011) Sudden cardiac death in haemodialysis patients: an in-depth review. Am J Kidney Dis 57(6): 921-929.
2. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO (2003) Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 14(10): 2623-2631.
3. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57(14): 1511-1522.
4. Sigrist MK, Chiarelli G, Levin A, Romann A, Weber C (2010) Pulse wave velocity measurements are reproducible in multiple trained observers: a short report. Nephron Clin Pract 116(1): c60-c64.
5. Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am J Kidney Dis 45(6): 965-977.
6. Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziráki A (2010) Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 28(10): 2068-2075.
7. Davies JM, Bailey MA, Griffin KJ, Scott DJ (2012) Pulse wave velocity and the non-invasive methods used to assess it: Complior, SphygmoCor, Arteriograph and Vicorder. Vascular 20(6): 342-349.
8. Vernon K, Peasegood J, Riddell A, Davenport A (2010) Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin Pract 117(4): c403-c408.
9. Davenport A (2009) Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton) 14: 455-461.
10. Willicombe MK, Vernon K, Davenport A (2010) Embolic complications from central venous haemodialysis catheters used with hypertonic citrate locking solution. Am J Kidney Dis 55(2): 348-351.
11. Sandhu E, Crawford C, Davenport A (2012) Weight gains and increased blood pressure in outpatient hemodialysis patients due to change in acid dialysate concentrate supplier. Int J Artif Organs 35(9): 642-647.
12. Booth J, Pinney J, Davenport A (2010) N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 5(6): 1036-1040.
13. Davenport A (2012) Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J Nephrol 36(4): 371-376.
14. Moran N, Buscombe J, Davenport A (2008) Predicting cardiac events using adenosine triphosphate myocardial perfusion scintography in renal transplant candidates. J Nephrol Renal Transplant 1: 41-52.
15. Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM (2010) Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: improving global outcomes controversies conference. Kidney Int 77(4): 273-284.
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W (2006) American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 7(2): 79-108.
17. Davenport A. Differences in prescribed Kt/V and delivered haemodialysis dose-why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target. Nephrol Dial Transplant. 2013. PMID: 23787543.
18. Nemcsik J, Egresits J, El Hadj Othmane T, Fekete BC, Fodor E, Szabó T, Járai Z, Jekkel C, Kiss I, Tislér A (2009) Validation of arteriograph-a new oscillometric device to measure arterial stiffness in patients on maintenance haemodialysis. Kidney Blood Press Res 32(3): 223-229.
19. The Reference Values for Arterial Stiffness' Collaboration (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 31(19): 2338-2350.
20. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2009) Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology (Carlton) 14(1): 105-112.
21. Utescu MS, Couture V, Mac-Way F, De Serres SA, Marquis K, Larivière R, Desmeules S, Lebel M, Boutouyrie P, Agharazii M (2013) Determinants of progression of aortic stiffness in haemodialysis patients: a prospective longitudinal study. Hypertension 62(1): 154-160.
22. Celik G, Demirci MS, Tumuklu M, Asci{dotless} G, Sipahi S, Toz H, Basci{dotless} A, Ok E (2011) Factors related to pulse wave velocity and augmentation index in chronic haemodialysis patients. Ren Fail 33(10): 957-963.
23. Kuang DW, Li CL, Kuok UI, Cheung K, Lio WI, Xin J (2012) Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao. BMC Nephrol 13: 143. doi: 10. 1186/1471-2369-13-143.
24. Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW (2011) Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant 26(10): 3296-3302.
25. Shigenaga A, Tamura K, Dejima T, Ozawa M, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Mitsuhashi H, Okano Y, Kokuho T, Sugano T, Ishigami T, Toya Y, Uchino K, Tokita Y, Umemura S (2009) Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodelling in hypertensive patients on chronic peritoneal dialysis. Nephron Clin Pract 112(1): c31-c40.
26. Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, Kim S, Oh YG, Yang J, Joo KW, Ahn C, Oh KH (2010) Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients. Nephrol Dial Transplant 25(12): 4041-4048.
27. Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC, NECOSAD Study Group (2011) Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 26(5): 1662-1669.
28. Shroff RC, Shanahan CM (2007) The vascular biology of calcification. Semin Dial 20(2): 103-109.
29. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19(9): 1827-1835.
30. Townsend RR, Chirinos JA, Parsa A, Weir MA, Sozio SM, Lash JP, Chen J, Steigerwalt SP, Go AS, Hsu CY, Rafey M, Wright JT Jr, Duckworth MJ, Gadegbeku CA, Joffe MP, Chronic Renal Insufficiency Cohort Investigators (2010) Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension 56(3): 518-524.
31. Jung JY, Hwang YH, Lee SW, Lee H, Kim DK, Kim S, Oh YG, Yang J, Joo KW, Ahn C, Oh KH. Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients.
32. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19: 179-184.
33. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349(5): 446-456.
34. Cozzolino M, Mehmeti F, Ciceri P, Volpi E, Stucchi A, Brenna I, Cusi D (2011) The effect of paricalcitol on vascular calcification and cardiovascular disease in uremia: beyond PTH control. Int J Nephrol 2011: 269060. doi: 10. 4061/2011/269060.